Moreover, the antifibrotic effect of NAOs was confirmed by immunoblotting and real-time PCR analysis of the major markers (PAI-1, α-SMA, and Col1A1) of liver fibrosis taken from three randomly selected mouse samples (Figure 5A–C). The gene discussed is ACTA1; the disease is Hepatic fibrosis.